tm
Seeing Is Believing
tm
Seeing Is Believing
ACRS is currently covered by 5 analysts with an average price target of $11.17. This is a potential upside of $7.38 (194.72%) from yesterday's end of day stock price of $3.79.
Aclaris Therapeutics's activity chart (see below) currently has 76 price targets and 94 ratings on display. The stock rating distribution of ACRS is 83.33% BUY and 16.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 23.36% with an average time for these price targets to be met of 116.57 days.
Highest price target for ACRS is $16, Lowest price target is $4, average price target is $11.17.
Most recent stock forecast was given by MARTIN FAN from WEDBUSH. First documented stock forecast 02-Nov-2015.
Currently out of the existing stock ratings of ACRS, 10 are a BUY (83.33%), 2 are a HOLD (16.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-May-2025
$8
$4.21 (111.08%)
$10
Buy Since 14-May-2025
$16
$12.21 (322.16%)
$16
Hold Since 06-Nov-2024
$4
$0.21 (5.54%)
$3
5 months 20 days ago
(08-May-2026)
4/5 (80%)
$-0.93 (-18.86%)
50
Buy Since 05-May-2026
$11
$7.21 (190.24%)
$6
5 months 23 days ago
(05-May-2026)
1/2 (50%)
$6.25 (131.58%)
391
Buy Since 29-Nov-2016
$12
$8.21 (216.62%)
5 months 23 days ago
(05-May-2026)
0/2 (0%)
$7.25 (152.63%)
What is ACRS (Aclaris Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on ACRS (Aclaris Therapeutics)?
Which analyst has the most public recommendations on ACRS (Aclaris Therapeutics)?
Which analyst is the currently most bullish on ACRS (Aclaris Therapeutics)?
Which analyst is the currently most reserved on ACRS (Aclaris Therapeutics)?
